What’s in Shortage

Generic Name: Dexamethasone Sodium Phosphate Injection
Brand Name: DEXAMETHASONE SODIUM PHOSPHATE
Dosage Form: Injection
Therapeutic Categories: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pulmonary/Allergy, Rheumatology, and others.
Current Status: The shortage is currently active as of the latest update on February 5, 2026. This shortage was initially posted on February 8, 2019.

Which Manufacturers Are Affected

Supply availability varies significantly by manufacturer and specific product presentation:

• Mylan Institutional, a Viatris Company (800-796-9526):

  • Available: All listed presentations, including 4 mg/1 mL and 10 mg/1 mL injections.

• Fresenius Kabi USA, LLC (888-386-1300):

  • Available: 4 mg/1 mL (NDCs 63323-165-01, 63323-165-30, 63323-165-05), 10 mg/1 mL Preservative Free (NDC 63323-506-01), and 10 mg/1 mL (NDC 76045-109-10).
  • Unavailable: 10 mg/1 mL (NDC 63323-516-10) with a next release date of March 2026; 4 mg/1 mL (NDC 76045-106-10) is currently not available.

• Eugia US LLC (888-238-7880):

  • Available: 10 mg/1 mL (NDC 55150-304-25).
  • Unavailable: 4 mg/1 mL (NDCs 55150-238-05, 55150-237-01, 55150-239-30) and 100 mg/10 mL (NDC 55150-305-10) are on backorder with recovery dates to be determined.

Why There’s a Shortage

The FDA source data does not provide a specific reason for the shortage, though several manufacturers indicate that specific presentations are currently on backorder.

What Patients Should Do

If you or a loved one relies on Dexamethasone Sodium Phosphate Injection, please consider the following steps:

• Consult Your Healthcare Provider: Speak with your doctor regarding your treatment plan. This article is for informational purposes and does not constitute medical advice.
• Talk to Your Pharmacist: Pharmacists often have the most up-to-date information on which specific NDCs (National Drug Codes) are currently in stock or available through wholesalers.
• Contact Manufacturers: You may use the contact numbers provided above to inquire about the availability of specific product presentations.

Source

Information provided by the FDA Drug Shortage Database. Last updated: February 5, 2026.